Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes Read more
US FDA approves Jardiance to treat adults living with heart failure with reduced ejection fraction Read more
AbCellera gets EUA from US FDA for its antibody Bamlanivimab, along with Etesevimab for COVID-19 Read more
